Open Actively Recruiting

Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants

About

Brief Summary

A comprehensive analysis of the impact of exogenous enteral DHA and ARA supplementation on lipid metabolism including the production of downstream derived mediators and how this impacts important biological pathways such as metabolism, inflammation, and organogenic factors.

Primary Purpose
Basic science
Study Type
Interventional
Phase
N/A

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
N/A
Maximum Age
36 Weeks

Inclusion Criteria:

  • born between 25 0/7 and 29 6/7 weeks of gestation
  • less than 48 hours of age at first lipid dose (The cohort is defined by gestational age rather than birth weight to avoid an over-represented sample of growth-restricted infants in birth weight defined cohorts.)

Exclusion Criteria:

  • serious congenital anomalies
  • conditions at birth that will require surgery prior to discharge
  • imminent death such that withdrawal of intensive care support is anticipated within the first 72 hours after birth

Join this Trial

Contact our clinical trial navigators for opportunities that may be suitable for you
Share:
Study Stats
Protocol No.
22-001345
Category
Pediatric and Prenatal Disorders
Contact
MARGARET BRADLEY
Location
  • UCLA Santa Monica
  • UCLA Westwood
For Providers
NCT No.
NCT05380401
For detailed technical eligibility, visit ClinicalTrials.gov.